Class 005: Pharmaceutical preparations and therapeutic agents for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; medicated skin care preparations, namely, creams and lotions; medicated skin care preparations, namely, creams and lotions for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; transdermal patches featuring pharmaceutical preparations and therapeutic agents for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder
Class 005: Pharmaceutical preparations and therapeutic agents for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; medicated skin care preparations, namely, creams and lotions; medicated skin care preparations, namely, creams and lotions for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; transdermal patches featuring pharmaceutical preparations and therapeutic agents for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder
Therapeutic agents for treatment of narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, and diseases having neurological symptoms or manifestations; Financial grant making and grant funding, namely, providing financial funding to non-profit organizations who work to address the challenges of individuals living with narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, or diseases having neurological symptoms or manifestations, and their caregivers; financial grant making and grant funding, namely, providing financial funding to non-profit organizations who work to address disparities and inequities in access to treatment and care for individuals living with narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, or diseases having neurological symptoms or manifestations; providing and administering the grant of educational scholarships; grant making, namely, providing grants for biomedical research; financial services, namely, funding research awards in the field of biomedical sciences; Promotion and public advocacy services, namely promoting the advancement of medical research and the curing of narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, and diseases having neurological symptoms or manifestations; promotion and public advocacy services, namely promoting the treatment of narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, and diseases having neurological symptoms or manifestations; promotion and public advocacy services, namely promoting the affordability of, increased access to, and equity regarding medical services and the treatment of narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, and diseases having neurological symptoms or manifestations; promotional and public advocacy services, namely, promotion for increased empathy and patient engagement for individuals living with narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, and diseases having neurological symptoms or manifestations; promoting public awareness of narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, and diseases having neurological symptoms or manifestations, and how such disorders affect individuals living with them; charitable services, namely, organizing and conducting volunteer programs and community service projects; "BIOSCIENCES"
Financial grant making and grant funding, namely, providing financial funding to non-profit organizations who work to address disparities and inequities in access to treatment and care for individuals living with narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, and diseases having neurological symptoms or manifestations; Promotion and advocacy services, namely promoting the advancement of medical research and the curing of narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, and diseases having neurological symptoms or manifestations; promotion and advocacy services, namely promoting the treatment of narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, and diseases having neurological symptoms or manifestations; promotion and advocacy services, namely advocating for affordability of, increased access to, and equity regarding medical services and the treatment of narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, and diseases having neurological symptoms or manifestations; promoting and advocating for increased empathy and patient engagement for individuals living with narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, and diseases having neurological symptoms or manifestations; promoting public awareness of narcolepsy, disorders of sleep and wakefulness, central nervous system disorders, and diseases having neurological symptoms or manifestations and how such disorders affect individuals living with them
